Crucially, even after this dip, the stock remains relatively expensive. This high valuation, combined with a track record of ...
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback